Scan brief descriptions of initiatives and work conducted by our center community and our decision science colleagues across the globe.

Regulatory Analysis: Distribution Effects?

Prior to putting forth a major health, environmental, or safety regulation, government agencies in the U.S. are generally expected to analyze the distribution of its impacts as well as its total costs and benefits. This review of several regulatory analyses found that agencies’ analyses provide little information on distributional impacts.

Valuing Mortality Risk Reduction

The value of mortality risk reductions, conventionally expressed as the value per statistical life, is an important determinant of the net benefits of many government policies. This review found that few studies of illness-related risks in the United States meet criteria for good quality, although those that do yield similar values to studies of injury-related risks.

Valuing nonfatal health risk

This study used a stated-preference survey fielded to an internet panel representative of the adult US population to estimate willingness to pay for small reductions in the risk of nonfatal health conditions, finding it is proportional to the stated reduction in probability of illness and is an increasing but highly concave function of the severity and duration of the illness.

Global Health 2035: Value of a Life Year

In "Global Health 2035," The  Lancet Commission on Investing in Health adds the value of increased life expectancy to the value of growth in GDP when assessing national well-being. This paper investigates the sensitivity of this estimate to underlying assumptions such as the effects of income, age, life expectancy, and the sequencing of calculations.

Regulatory Impact Analyses: Tips

Regulatory impact analyses (RIAs) weigh the benefits of regulations against the burdens they impose and can be important and useful tools for informing decision makers. This Consumer’s Guide to Regulatory Impact Analysis offers 10 tips for non-specialist policymakers, decision makers and interested stakeholders who will be reading RIAs as consumers.

Regulating HAPS: Size of Benefits?

This paper finds the monetized benefits for reductions in Hazardous Air Pollutants (HAPs) from coal and oil-fired utilities (EGUs) identified by the EPA in the regulatory impact analysis, specifically mercury emissions and exposures to its organic form, methylmercury, understate the benefits associated with reductions of those emissions.

Featured Resource: Benefit-Cost Analysis Reference Case Project

CHDS faculty and staff have undertaken a major project funded by the Bill and Melinda Gates Foundation to develop a “reference case” for BCA. The goal of the project is to encourage the conduct of high quality, comparable benefit‐cost analyses of initiatives designed to improve the health and well‐being of low‐ and middle‐income populations. Learn more.